JPM
59
6
XOM
33
3
UPS
51
6
VFC
56
6
KHC
11
2
ADP
57
2
FE
34
4
KR
50
5
NSC
33
6
AMGN
42
14
NTAP
58
3
MCD
52
3
BF.B
35
2
CNP
59
17
TROW
37
8
GWW
50
9
BLK
47
3
MAR
57
3
AXP
63
3
FIS
43
5
JPM
59
6
XOM
33
3
UPS
51
6
VFC
56
6
KHC
11
2
ADP
57
2
FE
34
4
KR
50
5
NSC
33
6
AMGN
42
14
NTAP
58
3
MCD
52
3
BF.B
35
2
CNP
59
17
TROW
37
8
GWW
50
9
BLK
47
3
MAR
57
3
AXP
63
3
FIS
43
5
Financhill
Back

Bluejay Diagnostics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
20

BJDX
Bluejay Diagnostics

Last Price:
$3.96
Seasonality Move:
-39.85%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
20
Bluejay Diagnostics (BJDX) is a Sell

Is Bluejay Diagnostics a Buy, Sell or Hold?

  • The current Bluejay Diagnostics [BJDX] share price is $3.91. The Score for BJDX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BJDX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BJDX Stock Price Chart

What is Bluejay Diagnostics's stock price today?

  • The Bluejay Diagnostics share price today is $3.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BJDX is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

BJDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 46.15 Sell
Chaikin Money Flow: -2792 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.35 - 4.65) Sell
Bollinger Bands (100): (2.64 - 12.7) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.71 - 15.03) Sell

BJDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.34 Sell
20-day SMA: 4.14 Sell
50-day SMA: 4.5 Sell
200-day SMA: 98.03 Sell
8-day EMA: 4.22 Sell
20-day EMA: 4.27 Sell
50-day EMA: 6.57 Sell
200-day EMA: 271.73 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.97 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.02 Sell

Bluejay Diagnostics Earnings Growth & BJDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Bluejay Diagnostics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):